Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exercise | 13 | 2023 | 451 | 3.170 |
Why?
|
| Cerebrovascular Circulation | 7 | 2023 | 211 | 2.490 |
Why?
|
| Vasodilation | 8 | 2021 | 114 | 2.220 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 4 | 2021 | 22 | 1.400 |
Why?
|
| Nitric Oxide Synthase | 4 | 2021 | 34 | 1.400 |
Why?
|
| Cerebral Arteries | 3 | 2019 | 33 | 1.310 |
Why?
|
| Exercise Test | 4 | 2020 | 246 | 1.010 |
Why?
|
| Muscle, Skeletal | 8 | 2021 | 578 | 0.930 |
Why?
|
| Hand Strength | 6 | 2021 | 33 | 0.920 |
Why?
|
| Boxing | 1 | 2022 | 3 | 0.810 |
Why?
|
| Forearm | 6 | 2019 | 36 | 0.800 |
Why?
|
| Hot Temperature | 1 | 2022 | 84 | 0.770 |
Why?
|
| High-Intensity Interval Training | 1 | 2020 | 9 | 0.720 |
Why?
|
| Executive Function | 1 | 2020 | 24 | 0.710 |
Why?
|
| Adult | 18 | 2023 | 7384 | 0.700 |
Why?
|
| omega-N-Methylarginine | 5 | 2021 | 11 | 0.650 |
Why?
|
| Hypoxia | 1 | 2019 | 85 | 0.640 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2017 | 2 | 0.590 |
Why?
|
| Sildenafil Citrate | 1 | 2017 | 4 | 0.590 |
Why?
|
| Young Adult | 12 | 2021 | 2582 | 0.590 |
Why?
|
| Cognition | 4 | 2021 | 294 | 0.560 |
Why?
|
| Vascular Stiffness | 1 | 2015 | 41 | 0.490 |
Why?
|
| Neurovascular Coupling | 3 | 2022 | 152 | 0.490 |
Why?
|
| Humans | 25 | 2023 | 26846 | 0.480 |
Why?
|
| Cyclooxygenase Inhibitors | 4 | 2021 | 25 | 0.470 |
Why?
|
| Female | 17 | 2023 | 14466 | 0.470 |
Why?
|
| Blood Flow Velocity | 4 | 2023 | 63 | 0.450 |
Why?
|
| Oxygen Consumption | 4 | 2019 | 173 | 0.440 |
Why?
|
| Male | 18 | 2021 | 12874 | 0.440 |
Why?
|
| Spectroscopy, Near-Infrared | 4 | 2021 | 72 | 0.430 |
Why?
|
| Regional Blood Flow | 6 | 2021 | 159 | 0.430 |
Why?
|
| Endothelium, Vascular | 1 | 2015 | 305 | 0.420 |
Why?
|
| Blood Pressure | 3 | 2023 | 351 | 0.400 |
Why?
|
| Hemodynamics | 4 | 2021 | 220 | 0.360 |
Why?
|
| Ventilators, Mechanical | 1 | 2009 | 10 | 0.340 |
Why?
|
| Fires | 1 | 2009 | 10 | 0.340 |
Why?
|
| Caffeine | 1 | 2009 | 38 | 0.330 |
Why?
|
| Ketorolac | 3 | 2021 | 9 | 0.300 |
Why?
|
| Resistance Training | 2 | 2022 | 190 | 0.280 |
Why?
|
| Middle Cerebral Artery | 2 | 2023 | 48 | 0.260 |
Why?
|
| Sleep Deprivation | 2 | 2021 | 27 | 0.240 |
Why?
|
| Enzyme Inhibitors | 2 | 2016 | 247 | 0.230 |
Why?
|
| Prefrontal Cortex | 2 | 2021 | 79 | 0.220 |
Why?
|
| Adolescent | 4 | 2020 | 2957 | 0.210 |
Why?
|
| Circulating MicroRNA | 1 | 2022 | 10 | 0.210 |
Why?
|
| Obesity | 2 | 2021 | 650 | 0.210 |
Why?
|
| Rest | 1 | 2023 | 93 | 0.200 |
Why?
|
| Acclimatization | 1 | 2022 | 29 | 0.200 |
Why?
|
| Athletes | 1 | 2022 | 68 | 0.190 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2021 | 54 | 0.190 |
Why?
|
| Sex Factors | 2 | 2020 | 445 | 0.190 |
Why?
|
| Motor Cortex | 1 | 2021 | 45 | 0.180 |
Why?
|
| Citrulline | 1 | 2020 | 2 | 0.180 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2021 | 19 | 0.180 |
Why?
|
| Isoproterenol | 2 | 2021 | 23 | 0.180 |
Why?
|
| Menstrual Cycle | 1 | 2020 | 22 | 0.180 |
Why?
|
| Vasodilator Agents | 1 | 2020 | 79 | 0.170 |
Why?
|
| Indomethacin | 1 | 2019 | 15 | 0.170 |
Why?
|
| Peripheral Arterial Disease | 1 | 2022 | 113 | 0.170 |
Why?
|
| Random Allocation | 1 | 2019 | 148 | 0.170 |
Why?
|
| Brain | 2 | 2021 | 699 | 0.160 |
Why?
|
| MicroRNAs | 1 | 2022 | 280 | 0.160 |
Why?
|
| Double-Blind Method | 1 | 2019 | 399 | 0.160 |
Why?
|
| Brachial Artery | 2 | 2019 | 36 | 0.160 |
Why?
|
| Heart Rate | 1 | 2020 | 374 | 0.160 |
Why?
|
| Biomarkers | 2 | 2019 | 733 | 0.160 |
Why?
|
| Oxygen | 1 | 2019 | 218 | 0.160 |
Why?
|
| Muscle Strength | 2 | 2021 | 214 | 0.150 |
Why?
|
| Cognitive Dysfunction | 1 | 2022 | 259 | 0.150 |
Why?
|
| Cyclic GMP | 1 | 2017 | 27 | 0.150 |
Why?
|
| Aging | 2 | 2022 | 945 | 0.140 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2015 | 22 | 0.130 |
Why?
|
| Vascular Resistance | 1 | 2015 | 50 | 0.120 |
Why?
|
| Ascorbic Acid | 1 | 2014 | 24 | 0.120 |
Why?
|
| Muscle Contraction | 1 | 2015 | 162 | 0.120 |
Why?
|
| Biochemical Phenomena | 1 | 2014 | 2 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2016 | 165 | 0.120 |
Why?
|
| Sex Characteristics | 1 | 2015 | 162 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2015 | 228 | 0.110 |
Why?
|
| Fatigue | 1 | 2014 | 57 | 0.110 |
Why?
|
| Metabolic Syndrome | 1 | 2014 | 77 | 0.110 |
Why?
|
| Exercise Tolerance | 1 | 2014 | 82 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2015 | 290 | 0.110 |
Why?
|
| Antioxidants | 1 | 2014 | 220 | 0.100 |
Why?
|
| Middle Aged | 4 | 2021 | 6820 | 0.090 |
Why?
|
| Ergonomics | 1 | 2009 | 2 | 0.090 |
Why?
|
| Perfusion | 2 | 2021 | 43 | 0.080 |
Why?
|
| Infusions, Intra-Arterial | 2 | 2016 | 5 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 802 | 0.060 |
Why?
|
| Aged | 3 | 2022 | 5168 | 0.060 |
Why?
|
| Postmenopause | 1 | 2022 | 83 | 0.050 |
Why?
|
| Vibration | 1 | 2022 | 78 | 0.050 |
Why?
|
| Arterioles | 1 | 2022 | 60 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2021 | 19 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2021 | 11 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2021 | 43 | 0.050 |
Why?
|
| Animals | 1 | 2015 | 9962 | 0.050 |
Why?
|
| Reaction Time | 1 | 2021 | 94 | 0.050 |
Why?
|
| Knee | 1 | 2021 | 25 | 0.050 |
Why?
|
| Blood Vessels | 1 | 2021 | 58 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2021 | 62 | 0.050 |
Why?
|
| Time Factors | 2 | 2015 | 1562 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2021 | 151 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 133 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2021 | 199 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 702 | 0.040 |
Why?
|
| Neurons | 1 | 2021 | 275 | 0.040 |
Why?
|
| Diffusion | 1 | 2019 | 37 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 43 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 2016 | 22 | 0.030 |
Why?
|
| Microcirculation | 1 | 2016 | 111 | 0.030 |
Why?
|
| Contrast Media | 1 | 2016 | 93 | 0.030 |
Why?
|
| Lower Extremity | 1 | 2015 | 82 | 0.030 |
Why?
|
| Arterial Pressure | 1 | 2014 | 9 | 0.030 |
Why?
|
| Dementia | 1 | 2016 | 87 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 93 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2014 | 116 | 0.030 |
Why?
|
| Age Factors | 1 | 2015 | 716 | 0.030 |
Why?
|
| Motor Activity | 1 | 2014 | 146 | 0.030 |
Why?
|
| Models, Biological | 1 | 2016 | 446 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 152 | 0.030 |
Why?
|
| Phenotype | 1 | 2014 | 667 | 0.020 |
Why?
|